Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
ACTIVE_NOT_RECRUITING
NCT06048718
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
28
Enrollment(s)
13
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
Metastatic Breast Cancer
RECRUITING
NCT07451431
Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
78
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Diabetic Peripheral Neuropathic Pain (DPNP)
RECRUITING
NCT06764875
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
840
Enrollment(s)
284
Study location(s)
INTERVENTIONAL (PHASE3)
HER2-positive Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
RECRUITING
NCT05681702
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
90
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease
NOT_YET_RECRUITING
NCT07454707
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
1,204
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE3)
Stroke, Ischemic
NOT_YET_RECRUITING
NCT07454668
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
20
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer
HER2-positive Breast Cancer
Brain Metastases
Cancer
Cancer Metastatic
RECRUITING
NCT06311214
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
500
Enrollment(s)
27
Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
RECRUITING
NCT06819007
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
582
Enrollment(s)
180
Study location(s)
INTERVENTIONAL (PHASE3)
Ovarian Cancer
1
2
3
4
5